NewLink Genetics Corporation (NASDAQ:NLNK)

CAPS Rating: 2 out of 5

Results 1 - 10 of 10

Recs

0
Member Avatar healthcarevalue (97.47) Submitted: 7/25/2015 9:27:02 PM : Outperform Start Price: $51.47 NLNK Score: -0.87

NewLink Genetics Corporation (NLNK) - debt/equity ratio of impressive 0.03. Return on Invested Capital (ROIC) is incredible at 76.85. Price/earnings ratio at 13.5 shows a stock that is not overpriced by any means. Market cap of 1.48B leaves potential for possible acquisition down the road.

Recs

0
Member Avatar racoveanul (80.80) Submitted: 6/28/2015 5:32:30 AM : Outperform Start Price: $44.02 NLNK Score: +16.42

NEWLINK GENETIC, ticker NLNK, has a TTM ROE calculated by Zacks of 85,08%. It's one of my LONG picks.

Recs

0
Member Avatar SpartanMAC (< 20) Submitted: 4/20/2015 10:43:28 PM : Outperform Start Price: $54.07 NLNK Score: -3.87

Top 30 rank with min 200M mkt. cap

Recs

0
Member Avatar Sparticus501 (< 20) Submitted: 10/10/2014 9:38:39 PM : Outperform Start Price: $18.65 NLNK Score: +164.75

Ebola is not going away. This stock should shoot up over the next 6 months.

Recs

1
Member Avatar Dennyboy01 (< 20) Submitted: 1/13/2014 10:56:11 AM : Outperform Start Price: $25.18 NLNK Score: +90.03

This company appears to be on track in developing products to fight cancer and should be a good buyout candidate.

Recs

1
Member Avatar mdoyle3834 (< 20) Submitted: 1/8/2014 7:03:08 AM : Outperform Start Price: $22.76 NLNK Score: +111.25

Newlink is involved in pancreatic cancer drug research. The stock is lifting off.

Recs

1
Member Avatar zzlangerhans (99.72) Submitted: 4/30/2013 7:42:12 PM : Underperform Start Price: $12.40 NLNK Score: -280.75

I laid out the reasons why I think HyperAcute Pancreas will fail here in February: http://caps.fool.com/Pitch/NLNK/6662267/newlinks-most-advanced-clinica.aspx

After closing my prior underperform for a win I'm back in red and quickly down 12 points. This is a case where I hope I go negative as much as possible because NewLink in looking like a great candidate for puts prior to the interim data expected in mid-2013. I'll keep my ear to the ground for more specific information regarding the data release, which was already pushed back very quietly from April, and update this pitch with put prices and my position, if any.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:11:13 PM : Outperform Start Price: $17.18 NLNK Score: +140.40

porto. likededd it.

Recs

0
Member Avatar GregoryGK (< 20) Submitted: 6/16/2012 9:24:28 AM : Outperform Start Price: $15.80 NLNK Score: +167.83

High risk but potential high reward.

Recs

0
Member Avatar ta2122 (28.30) Submitted: 2/7/2012 2:59:17 PM : Underperform Start Price: $7.00 NLNK Score: -573.84

Never has had income. Now with more cash it will? No. Earnings move stocks, not charts.

Results 1 - 10 of 10

Featured Broker Partners


Advertisement